Drug intelligence / Profile preview

salvia officinalis leaf extract

Development stage
Unknown
Lead developer
Aboca
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Salvia officinalis leaf extract is a freeze-dried botanical extract derived from the leaves of the sage plant (*Salvia officinalis*). Developed by the Italian company ABOCA, it is being investigated as a natural phytocomplex therapeutic for the management of postoperative pain, often in combination with *Helichrysum italicum* extract. The extract contains a complex mixture of phytochemicals, including rosmarinic acid, flavonoids, and terpenoids, which exhibit anti-inflammatory and analgesic properties. Its mechanism of action likely involves the modulation of inflammatory mediators such as prostaglandins, cytokines, and cyclooxygenase (COX) enzymes. It has been evaluated in Phase 2 clinical trials for its efficacy in reducing pain following surgical procedures.

Other names
sage leaf extractSalvia officinalis extract
02

Targets

PTGES (Microsomal prostaglandin E synthase-1)RELA (Nuclear Factor Kappa B Subunit p65)PTPN1 (Protein tyrosine phosphatase 1B)

Beyond the preview

Go deeper on salvia officinalis leaf extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on salvia officinalis leaf extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call